The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Meningococcal ACWY (MenACWY) Conjugate Vaccine belonging to the Vaccination Programme in the Finnish Defence Forces and for the medical risk groups within the National Vaccination Programme in Finland.
The contract period is about two years during 2021-2023. The procurement contains two options to extend the contract for the periods 2023-2024 and 2024-2025.
Estimated quantity for the contract period including option is 120 000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %.
The contract will be awarded to one supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the call for tender refer to local time in Finland.
Tender Annexes:
— Annex 1: Contract;
— Annex 2: JYSE 2014 Supplies (Updated April 2017) (link).
Määräaika
Tarjousten vastaanottamisen määräaika oli 2021-01-29.
Hankinta julkaistiin 2020-12-22.
Toimittajat
Seuraavat toimittajat mainitaan hankintapäätöksissä tai muissa hankinta-asiakirjoissa:
Kohde Hankinnan laajuus
Otsikko:
“Meningococcal ACWY Conjugate Vaccine (MenACWY) 2021-2023 (2023-2024, 2024-2025)
VN/1166/2020”
Tuotteet/palvelut: Rokotteet📦
Lyhyt kuvaus:
“The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your...”
Lyhyt kuvaus
The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Meningococcal ACWY (MenACWY) Conjugate Vaccine belonging to the Vaccination Programme in the Finnish Defence Forces and for the medical risk groups within the National Vaccination Programme in Finland.
The contract period is about two years during 2021-2023. The procurement contains two options to extend the contract for the periods 2023-2024 and 2024-2025.
Estimated quantity for the contract period including option is 120 000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %.
The contract will be awarded to one supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the call for tender refer to local time in Finland.
Tender Annexes:
— Annex 1: Contract;
— Annex 2: JYSE 2014 Supplies (Updated April 2017) (link).
1️⃣
Suorituspaikka: Suomi/Finland🏙️
Hankinnan kuvaus:
“The purpose of STM and the customer is to procure Meningococcal ACWY (MenACWY) conjugate vaccine required for the vaccination programme in the Finnish...”
Hankinnan kuvaus
The purpose of STM and the customer is to procure Meningococcal ACWY (MenACWY) conjugate vaccine required for the vaccination programme in the Finnish Defence forces and for the medical risk groups within the National Vaccination Programme in Finland. Tendered vaccine must be suitable for adults and children because both adults and children may belong to the Medical Risk Groups. The customer will implement the procurement on behalf of STM. The roles of STM and customer are described in more detail in section ‘Presentation of the contracting authority’.
The subject of procurement and the mandatory requirements relating to it are described in detail in this call for tender and its Annexes. The contract will be awarded to one supplier based on a comparison of tenders.
Contract Period
The contract's duration is about 2 years. Estimated quantity for the contract period is 60 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %.
The contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. After the contract period, the customer reserves the right for the option described in section ‘Description of renewals’.
Tenders will be compared in the manner described in section ‘Grounds for decision’ of the call for tender.
Näytä lisää Myöntämisperusteet
Hinta
Sopimuksen, puitesopimuksen tai dynaamisen hankintajärjestelmän kesto
Jäljempänä oleva aikataulu on ilmaistu kuukausina.
Kuvaus
Kesto: 24
Sopimuksen, puitesopimuksen tai dynaamisen hankintajärjestelmän kesto
Tämä sopimus voidaan uusia ✅ Kuvaus
Uudistusten kuvaus:
“The procurement contains 2 option years (1 + 1) to extend the contract. Estimated quantity for each option period is 30 000 doses (+/- 20 %). The customer...”
Uudistusten kuvaus
The procurement contains 2 option years (1 + 1) to extend the contract. Estimated quantity for each option period is 30 000 doses (+/- 20 %). The customer can extend the contract 1 year at a time.
Näytä lisää
Lisätietoja:
“This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the HILMA Public Procurement website...”
Lisätietoja
This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the HILMA Public Procurement website as well as this call for tender and its Annexes.
Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot Osallistumisehdot
Luettelo ja lyhyt kuvaus olosuhteista:
“Please see sections other information of the call for tender and the European Single Procurement Document (ESPD).” Taloudellinen ja rahoituksellinen asema
Hankinta-asiakirjoissa mainitut valintaperusteet
Tekninen ja ammatillinen pätevyys
Hankinta-asiakirjoissa mainitut valintaperusteet
Sopimukseen liittyvät ehdot
Sopimuksen täytäntöönpanoehdot:
“Please see sections other information of the call for tender and the European Single Procurement Document (ESPD).”
Menettely Toimenpiteen tyyppi
Avoin menettely
Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2021-01-29
12:00 📅
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Jäljempänä oleva aikataulu on ilmaistu kuukausina.
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 6
Tarjousten avaamista koskevat ehdot: 2021-01-29
13:00 📅
Tarjousten avaamista koskevat ehdot (paikka): The opening of the tenders is not a public event.
Täydentävät tiedot Tietoa toistumisesta
Tämä on toistuva hankinta ✅
Arvioitu aikataulu uusien ilmoitusten julkaisemiselle: The following procurement is estimated to happen in 2024.
Tietoa sähköisistä työnkuluista
Sähköistä tilaamista käytetään
Sähköistä maksua käytetään
Lisätietoja
“Tenderers may ask clarification questions using the supplier portal. The questions must be in English and will be answered in English. To guarantee the...”
Tenderers may ask clarification questions using the supplier portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered.
Please note that all times given in the call for tender refer to local time in Finland.
Please note that the online connection to the supplier portal is periodically slow and the download time will take time. Please fill out the tenders information in good time before the deadline expires.
This notice has links and/or attachments listed in https://www.hankintailmoitukset.fi/en/public/procurement/45464/notice/61180
Ilmoitus tehdystä sopimuksesta (2021-09-17) Hankintaviranomainen Nimi ja osoitteet
Nimi: Terveyden ja hyvinvoinnin laitos
Kansallinen rekisterinumero: 2229500-6
Postiosoite: PL 30
Postinumero: 00271
Yhteyshenkilö: Finnish Institute for Healh and Welfare (THL)
Sähköposti: jenni.tiainen@thl.fi📧
Alue: Helsinki-Uusimaa🏙️
URL: http://www.thl.fi/🌏
Kohde Hankinnan laajuus
Otsikko:
“Meningococcal ACWY Conjugate Vaccine (MenACWY) 2021- 2023 (2023- 2024, 2024-2025)
THL/4981/8.00.02/2020”
Lyhyt kuvaus:
“The purpose of STM and the THL is to procure Meningococcal ACWY (MenACWY) Conjugate Vaccine required for the vaccination programme in the Finnish Defence...”
Lyhyt kuvaus
The purpose of STM and the THL is to procure Meningococcal ACWY (MenACWY) Conjugate Vaccine required for the vaccination programme in the Finnish Defence forces and for the medical risk groups within the National Vaccination Programme in Finland. Tendered vaccine must be suitable for adults and children because both adults and children may belong to the medical risk groups.
Näytä lisää
Hankinnan kokonaisarvo (ilman arvonlisäveroa): EUR 2604000.0 💰
Kuvaus
Suorituspaikka: Manner-Suomi🏙️
Hankinnan kuvaus:
“The purpose of STM and the THL is to procure Meningococcal ACWY (MenACWY) Conjugate Vaccine required for the vaccination programme in the Finnish Defence...”
Hankinnan kuvaus
The purpose of STM and the THL is to procure Meningococcal ACWY (MenACWY) Conjugate Vaccine required for the vaccination programme in the Finnish Defence forces and for the medical risk groups within the National Vaccination Programme in Finland. Tendered vaccine must be suitable for adults and children because both adults and children may belong to the medical risk groups.
Näytä lisää Tietoa vaihtoehdoista
Vaihtoehdot ✅
Vaihtoehtojen kuvaus:
“The procurement contains two option years (1+1) to extend the contract. Estimated quantity for each option period is 30 000 doses (+/- 20%). The Customer...”
Vaihtoehtojen kuvaus
The procurement contains two option years (1+1) to extend the contract. Estimated quantity for each option period is 30 000 doses (+/- 20%). The Customer can extend the contract one year at a time.
Menettely Hallinnolliset tiedot
Tätä menettelyä koskeva aiempi julkaisu: 2020/S 251-628504
Sopimuksen tekeminen
1️⃣
Sopimuksen numero: 2021-082053-001-001
Otsikko:
“Contract for the Procurement of Meningococcal ACWY Conjugate Vaccine (MenACWY) 2021- 2023 (2023- 2024)”
Sopimuksen tekopäivä: 2021-08-20 📅
Tietoa tarjouskilpailuista
Saatujen tarjousten määrä: 2
Toimeksisaajan nimi ja osoite
Nimi: GlaxoSmithKline Oy
Kansallinen rekisterinumero: FI01083784
Postitoimipaikka: Espoo
Maa: Suomi 🇫🇮
Alue: Helsinki-Uusimaa🏙️
Toimeksisaaja on pk-yritys
Tiedot sopimuksen/erän arvosta (ilman alv:tä)
Sopimuksen/osuuden kokonaisarvo: EUR 2604000.0 💰
Täydentävät tiedot Arvostelurunko
Nimi: Markkinaoikeus
Lähde: OJS 2021/S 184-478422 (2021-09-17)